Target intelligence / Profile preview

Nucleotide-binding domain (NBD)

Target
NBD
Molecular classification
Enzyme, Transporter, Receptor, Other
01

Overview

The nucleotide-binding domain (NBD) is a highly conserved structural motif found in a diverse array of proteins, most notably within the ATP-binding cassette (ABC) transporter superfamily and the NOD-like receptor (NLR) family. Its primary biological function is to bind and hydrolyze ATP, providing the energy required for various cellular processes such as the active transport of substrates across membranes or the assembly of large signaling complexes like the inflammasome. In the context of disease, mutations or dysregulation of NBD-containing proteins are central to conditions such as cystic fibrosis (CFTR), multidrug resistance in cancer (P-glycoprotein), and chronic inflammatory disorders (NLRP3). Pharmacologically, the NBD is a critical target for small-molecule inhibitors and modulators; for instance, NLRP3 inhibitors like MCC950 bind directly to the NBD to prevent activation, while CFTR correctors like lumacaftor target NBD1 to stabilize protein folding. Due to its ubiquity and conservation, the NBD serves as a 'model' for rational drug design aimed at modulating enzymatic activity and protein-protein interactions across multiple therapeutic areas.

Other names
ATP-binding domainABC domainNACHT domainNucleotide-binding foldRossmann fold
02

Biological functions

ATP hydrolysisSignal transductionIon transportInflammasome activationProtein folding regulation
03

Disease associations

Cystic fibrosisCancer (Multidrug resistance)Inflammatory diseaseNeurodegenerative diseaseDiabetes (Type 2)
04

Safety considerations

Off-target effects due to high structural conservation across different protein familiesPotential for systemic toxicity if essential ABC transporters are inhibitedChallenges in achieving isoform-specific inhibition
05

Interacting drugs

MCC950

5 more in the full profile.

06

Biomarkers

Interleukin-1 beta (IL-1β)Chloride transport efficiencyATPase activity levelsC-reactive protein (CRP)

Beyond the preview

Go deeper on Nucleotide-binding domain (NBD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleotide-binding domain (NBD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call